Schwartz Carl I. 4

Accession 0001179110-20-009648

CIK 0001446159other

View on SEC.gov Company Profile

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 8:54 PM ET

Size

62.7 KB

Accession

0001179110-20-009648

Insider Transaction Report

Form 4

Period: 2020-09-04

Predictive Oncology Inc.POAI

Schwartz Carl I.

10% Owner

Transactions

Award
Stock Options (Right to buy)
2020-09-04+52→ 52 total
Exercise: $1.54Exp: 2025-06-30→ Common Stock (52 underlying)
Award
Stock Options (Right to buy)
2020-09-04+714→ 714 total
Exercise: $1.54Exp: 2026-12-31→ Common Stock (714 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−37,691→ 0 total
Exercise: $14.70Exp: 2027-06-22→ Common Stock (37,691 underlying)
Award
Common Stock (Right to buy)
2020-09-04+37,691→ 37,691 total
Exercise: $1.54Exp: 2027-06-22→ Common Stock (37,691 underlying)
Disposition to Issuer
Stock Options (right to buy)
2020-09-04−52→ 0 total
Exercise: $775.00Exp: 2025-06-30→ Common Stock (52 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−714→ 0 total
Exercise: $28.00Exp: 2026-12-31→ Common Stock (714 underlying)
Award
Stock Options (Right to buy)
2020-09-04+2,834→ 2,834 total
Exercise: $1.54Exp: 2027-11-10→ Common Stock (2,834 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−12,168→ 0 total
Exercise: $11.30Exp: 2028-06-30→ Common Stock (12,168 underlying)
Award
Stock Options (Right to buy)
2020-09-04+4,490→ 4,490 total
Exercise: $1.54Exp: 2028-08-01→ Common Stock (4,490 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−238→ 0 total
Exercise: $21.00Exp: 2027-03-31→ Common Stock (238 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−133→ 0 total
Exercise: $37.50Exp: 2026-06-30→ Common Stock (133 underlying)
Award
Stock Options (Right to buy)
2020-09-04+133→ 133 total
Exercise: $1.54Exp: 2026-06-30→ Common Stock (133 underlying)
Award
Stock Options (Right to buy)
2020-09-04+59→ 59 total
Exercise: $1.54Exp: 2026-03-31→ Common Stock (59 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−2,834→ 0 total
Exercise: $14.70Exp: 2027-11-10→ Common Stock (2,834 underlying)
Award
Stock Options (Right to buy)
2020-09-04+32,305→ 32,305 total
Exercise: $1.54Exp: 2029-01-02→ Common Stock (32,305 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−14,178→ 0 total
Exercise: $9.70Exp: 2028-01-02→ Common Stock (14,178 underlying)
Award
Stock Options (Right to buy)
2020-09-04+14,178→ 14,178 total
Exercise: $1.54Exp: 2028-01-02→ Common Stock (14,178 underlying)
Award
Common Stock (Right to buy)
2020-09-04+12,168→ 12,168 total
Exercise: $1.54Exp: 2028-06-30→ Common Stock (12,168 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−4,490→ 0 total
Exercise: $11.60Exp: 2028-08-01→ Common Stock (4,490 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−32,305→ 0 total
Exercise: $6.19Exp: 2029-01-02→ Common Stock (32,305 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−7→ 0 total
Exercise: $2812.50Exp: 2023-07-19→ Common Stock (7 underlying)
Award
Stock Options (Right to buy)
2020-09-04+7→ 7 total
Exercise: $1.54Exp: 2023-07-19→ Common Stock (7 underlying)
Award
Stock Options (Right to buy)
2020-09-04+238→ 238 total
Exercise: $1.54Exp: 2027-03-31→ Common Stock (238 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−179→ 0 total
Exercise: $28.00Exp: 2026-12-31→ Common Stock (179 underlying)
Award
Stock Options (Right to buy)
2020-09-04+179→ 179 total
Exercise: $1.54Exp: 2026-12-31→ Common Stock (179 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−121→ 0 total
Exercise: $41.25Exp: 2026-09-30→ Common Stock (121 underlying)
Award
Stock Options (Right to buy)
2020-09-04+121→ 121 total
Exercise: $1.54Exp: 2026-09-30→ Common Stock (121 underlying)
Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−59→ 0 total
Exercise: $42.50Exp: 2026-03-31→ Common Stock (59 underlying)

Holdings

Common Stock
1,611,981

Footnotes (3)

[F1]All transactions reported on this form involve the repricing of stock options with an exercise price greater than $1.54 to an exercise price of $1.54, as approved by shareholders at the 2020 annual meeting, with certification of the shareholder vote as of September 4, 2020.
[F2]Currently exercisable.
[F3]Held by the Carl I. Schwartz Revocable Living Trust

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

Predictive Oncology Inc.

CIK 0001446159

→

Entity typeother

Related Parties

filerCIK 0001573354

Filing Metadata

Form type: 4
Filed: Sep 8, 8:00 PM ET
Accepted: Sep 9, 8:54 PM ET
Size: 62.7 KB

View on SEC.gov